Filing Details
- Accession Number:
- 0000899243-18-006756
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-07 20:38:47
- Reporting Period:
- 2018-03-06
- Accepted Time:
- 2018-03-07 20:38:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1607737 | D Renee Gala | C/O Corcept Therapeutics Incorporated 149 Commonwealth Drive Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-03-06 | 1,000 | $15.30 | 1,000 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2018-03-07 | 9,000 | $15.53 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $15.5334 to $15.5399 per share. Detailed information on the exact number of shares purchased at each purchase price can be obtained from the issuer upon request.